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Objective : Evaluation by radio frequency in real-time, the quality of arte-
rial rigidity in patients with cardiovascular risk factors. 
Method: 3 measurements each carotid artery to determined coefficients,
parameters rigidity, velocity of wave of pulse according by age. Quality of the
rigidity of the arterial wall is measured from the velocity of the wave of pulse
(PWV), variation of arterial diameter blood pressure on level of humeral
artery, with measures of rigidity parameters. 
Results: 2 carotid axes: 200 patients, 3 groups (age 30- 69) according by
age, sex,race 2 groups: white race, dyslipidemia, type II diabetes, smoking:
according by sex. 1 group: 60 M, white race, the 2 group: 40 F (white race),
3 group 50 patients (hypertension, overweight) according to the sex and race;
in 2 sub-groups: group A 25 M (20 white race, 5 black) group B 25 F white
race. Brachial blood pressure calculated to obtain the velocity of the wave of
pulse, coefficients of arterial rigidity, local pressure. The pathological wave of
pulse >13m/s, coefficients of rigidity:  >11, ß > 20. In the 2 groups (10% men,
8% women) had pathological >11, ß>20 and velocity propagation of PWV
>13 m/s. In 3 group 20% M, 12% F with hypertension, pathological rigidity,
local pressure systolic increased despite the treatment. 
Conclusion: QAS non invasive mesure of arterial rigidity on carotid, inde-
pendent marker, in patients with cardiovascular risk factors, study the local
and central blood pressure hypertensive patients to better control a pharmaco-
logical therapy. QAS by radiofrequency calculation of arterial rigidity on
carotid level, parameters of rigidity , , and velocity of propagation of wave of
pulse, the local and central pressure of the studied artery. In 1 and 2 group,
patients with nicotinic intoxication and risk factors, in 3 group (hypertension,
overweight) not find pathological data neither differences according to the sex
and the race among all hypertensive patients. 2 patients of race black, 5 of the
sub-group (hypertension) with pathological coefficient > 11. 
QAS: calculation of arterial rigidity, RF: radio frequency, PWV (wave
velocity pulse), , ß : stiffness parameters .
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Objectives: To verify if HDL3 Anionic Peptide Factor (HDL3-APF) is as
an apolipoprotein that promotes the reverse cholesterol transport.
Design and Methods: We investigated a possible association between
plasma HDL3-APF concentration, cholesterol efflux from Fu5AH cells and
cholesteryl ester transfer protein (CETP) activity in type 2 diabetic patients
with coronary artery disease (CAD) (n=36), those without CAD (n=20), and
37 healthy subjects.
Results: Plasma APF concentrations were decreased in diabetics with CAD
compared to controls (p<0.01). Cellular cholesterol efflux was decreased in
diabetics without and with CAD, (p<0.01 and p<0.001 respectively). CETP
activity was significantly elevated in all patient groups. Multiple linear regres-
sion analysis shows that cholesterol efflux was independently and positively
related only to APF concentrations in whole population and controls.
Conclusions: APF is likely to be a key independent factor for promoting
cellular cholesterol efflux in healthy subjects. However this association is
altered in type 2 diabetes.
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Background: Food items might have a synergistic and antagonistic effect
on health. The Mediterranean diet (MD) has long been associated with lower
incidence of cardiovascular disease and cancer. Elevated blood homocysteine
is a risk factor for cardiovascular disease. A 5-mmol/L increase is associated
with an approximately 70% increase in relative risk of cardiovascular disease
in adults. For patients with established risk factors, this risk is likely even
greater. Thiolactonase; the antioxidant enzymatic component of HDL plays a
crucial role in metabolizing homocysteine thiolactone and reducing homocys-
teine endothelial damages.
Objective: A total of 53 elderly coronary artery disease patient swere
recruited and divided into diabetic patient (n= 27; age= 68.3 years) and non
diabetics (n = 26; age= 68.7 years). We evaluated plasma homocysteine levels
(tHcy); thiolactonase activity (HTase) and studied the effects of  adherence to
a Mediterranean diet on them.
Material & methods: Plasmatic tHcy was determined by capillaryGC-MS;
HTLase activity was estimated by a kit immunoassay. Dietary intakes were
evaluated by a validated food frequency questionnaire and transformed into a
score traducing adherence to MD.
Results: Significantly higher median tHcy levels were found in diabetic
patients as compared to the non diabetic ones (18.5 µmol/L vs. 5.8 ; p=0.057)
associated to lower HTase activities (266.8U/L vs. 327.4; p=0.058).  More-
over, in the diabetic patients tHcy levels were negatively associated with thi-
olactonase activities (r= -0.637; p 0.00). In this group, MD reduced diastolic
blood pressure (r= -0.558; p=0.014). In the non diabetic group, tHcy levels
were negatively correlated with HTase activities (r=0.759; p=0.00) and diet
score (r= -0.0706; p=0.013) while HTase activities were positively correlated
with diet score (r= 0.0759; p= 0.00).  
Conclusion: Elevated homocysteine in diabetic patients may partly be
explained by the diminished thiolactonase activities and could be considered
as an additional risk factor for cardiovascular events. Adherence to MD could
be the first efficient step to prevent these complications.
